By A Mystery Man Writer
Figure 1 from Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study - ScienceDirect
How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults - ScienceDirect
Udo BODE, University of Bonn, Bonn, Uni Bonn
Treatment outline ALL-BFM 95. Details of treatment elements are listed
Frontiers Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy
Outline of JACLS ALL-02 treatment. Details of treatment elements are
JKMS :: Journal of Korean Medical Science
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic